logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table HSR-4. Needle and syringe programmes (NSPs) [see all tables in this series...]

Part (i) Year of introduction of needle and syringe programmes (NSPs), types of programmes available in 2009 and number of sites

CountryNeedle and syringe fixed programmesOutreach NSP
Year first NSPSourcesYear first publicly fundedSourcesNo. of specialist agency sites with NSPNo. of vending machinesNo.of Pharmacy-based NSP sitesNo. of prison-based NSP sitesTotal number of fixed sites (min)No.of sites with NSP outreach workersNo. of sites where NSP carried out by vanTotal number of pharmacies
Belgium (Flemish Community)200112001115028043002710
Belgium (French Community)1994120001160:0161002464
Bulgaria1995119991100001074:4825
Czech Republic1986319913501005145:2600
Denmark1986119861:::0::0318
Germany1984419922:161:1::::
Estonia19971200111300013230486
Ireland198951989128000284:1394
Greece1998119981400041111000
Spain198511985112740965402279:3521166
France(1)1989119951116276:0392914922386
Italy1990119901::00::::
Cyprus20072200791000100446
Latvia1997119971180001873843
Lithuania199711997890009531504
Luxembourg1993119931440190092
Hungary199412000117500221242804
Malta19871198767000700:
Netherlands19847198611500250175::1948
Austria19901199011515:030102271
Poland1989119891240002412113 500
Portugal1993119931140136021376961502849
Romania20002200024003736365900
Slovenia19921199611102013::294
Slovakia199411994180008331950
Finland19971199714000040::811
Sweden(2)19861198612000200945
U. K. (England)1986119871:1:0:416197
U. K. (N. Ireland)2001220012101201300520
U. K. (Scotland)19872198724101690210128:
Croatia:1996270:074024:
Turkeyn/an/a0000000:
Norway1988119881241002522663

Notes:

 NSP: the acronym NSP is the abbreviation for the term ‘needle and syringe programme’. This means the provision of sterile syringes and hypodermic needles as well as of further injecting paraphernalia to injecting drug users. NSPs can also be implemented at pharmacies or in prisons.       

 NSP site: The term ‘site’ is used to describe physically distinct outlets where syringes can be obtained for free or in exchange against used ones.       

 Where data are not available, the table entry is left empty.                     

 (1) For France, Circulaire DGS 05 May 1992 allowed a pilot study of NSPs, but full implementation only after 1995.                 

 (2) In Sweden, needle and syringe programmes were run on a pilot basis from 1986 until 2006, when they were regularised through the Injection Needle Exchange Act (2006:233).         

 See also 'General notes for interpreting data' on the Explanatory notes and help page.         

Sources:

 Updated according to information in          

 (1) Structured questionnaire 23 'Prevention of infectious diseases', submitted by NFPs in 2004.         

 (2) Reitox National Report 2007.         

 (3) Personal communication, B. Korcisova, 9.3.2005.         

 (4) Personal communication, H. Stöver, 31.1.2005.         

 (5) Standard tables on 'syringe availability' (ST10), submitted by NFPs in 2004 and 2006. 

 (6) Personal communication, M. Camilleri, 14.2.2005.         

 (7) Coutinho, R. (1995), American Journal of Public Health 85, 1490-1.         

 (8) Personal communication E. Subata, 28.2.2005.         

 (9) Personal communication NFP, 11.4.2011.         

 NSP sites and total number of pharmacies information: Standard table on 'syringe availability' (ST10), submitted by NFPs in 2010 and Reitox National Report 2010.           

(see the help page for information about formats etc.)

Page last updated: Thursday, 16 June 2011